Endocrinology, Vol 125, 1239-1245, Copyright © 1989 by Endocrine Society

ARTICLES

Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells

G Maor, Z Hochberg, K von der Mark, D Heinegard and M Silbermann
Laboratory for Musculoskeletal Research, Faculty of Medicine, Technion- Israel Institute of Technology, Haifa.

GH is a systemic promoter of skeletal growth which increases the synthesis of insulin-like growth factor I in parenchymal tissues as well as in peripheral tissues such as the liver and growing cartilage. The present study was designed to examine whether GH possesses a direct effect on cellular proliferation and differentiation in mouse condylar cartilage. Cartilage progenitor cells were cultured in the form of a tissue culture on top of collagen sponges in medium containing 10% fetal calf serum and were treated with 50 ng/ml GH for 6 days. Three- day incubation with GH caused a marked increase in DNA synthesis and in the size of the culture, which developed into a nodule of differentiated chondrocytes and a well developed perichondrial layer around it. The effect of GH was even more pronounced after 6 days in culture; at which time a distinct network of trabeculae was noted throughout the extracellular matrix. The trabeculae contained osteocyte- like cells and were in close contact with both osteoblast-like and osteoclast-like cells. Using antibodies against bone-specific antigens, i.e. osteocalcin and osteopontin, provided further support for the notion that the newly formed trabecular formation was comprised of bone matrical components. Untreated control cultures lacked such structures, but contained hyaline-like cartilage. It, therefore, seems reasonable to suggest that GH induces a strong stimulatory effect on progenitor cell proliferation, cartilage differentiation, and extracellular mineralization, which supports de novo bone formation in vitro.

This article has been cited by other articles:

				H Kjellberg and K. A. Wikland A longitudinal study of craniofacial growth in idiopathic short stature and growth hormone-deficient boys treated with growth hormone Eur J Orthod, June 1, 2007; 29(3): 243 - 250. [Abstract] [Full Text] [PDF]

				E Mrak, I Villa, R Lanzi, M Losa, F Guidobono, and A Rubinacci Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cells J. Endocrinol., March 1, 2007; 192(3): 639 - 645. [Abstract] [Full Text] [PDF]

				M. Lampit and Z.'e. Hochberg Prevention of Growth Deceleration after Withdrawal of Growth Hormone Therapy in Idiopathic Short Stature J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3573 - 3577. [Abstract] [Full Text] [PDF]

				L. Rui, S. F. Archer, L. S. Argetsinger, and C. Carter-Su Platelet-derived Growth Factor and Lysophosphatidic Acid Inhibit Growth Hormone Binding and Signaling via a Protein Kinase C-dependent Pathway J. Biol. Chem., January 28, 2000; 275(4): 2885 - 2892. [Abstract] [Full Text] [PDF]

				C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg Growth Hormone and Bone Endocr. Rev., February 1, 1998; 19(1): 55 - 79. [Abstract] [Full Text]

				R. Quarto, G. Campanile, R. Cancedda, and B. Dozin Modulation of Commitment, Proliferation, and Differentiation of Chondrogenic Cells in Defined Culture Medium Endocrinology, November 1, 1997; 138(11): 4966 - 4976. [Abstract] [Full Text] [PDF]